Sol-Gel Reports Third Quarter 2024 Financial Results and Provides Corporate Updates Sol-Gel Reports Third Quarter 2024 Financial Results and Provides Corporate Updates

Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to Commercialize TWYNEO® in the Mainland of China, Hong Kong, Macau, Taiwan and Israel Sol-Gel and Beimei Pharma annouce an Asset Purcase Agreement to commercialize TWYNEO® in the Mainland of China, Hong Kong, Macau, Taiwan and Israel

Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments Sol-Gel Reports Full Year 2023 Financial Results and Corporate Developments

Arrival of Aurora’s Cannabis Material at Pharmacy Australia Centre of Excellence VANCOUVER, B.C., March 29, 2018 (GLOBE NEWSWIRE) -- via NetworkWire -- PreveCeutical Medical Inc. (the “Company” or “PreveCeutical”) (CSE:PREV) (OTCQB:PRVCF) (FSE:18H), announces the arrival of the...

Biopolymer Films Market to exceed $6bn by 2024: Global Market Insights Inc. Ocean View, Delaware, March 15, 2017 (GLOBE NEWSWIRE) -- The research report “Biopolymer Films Market Size By Raw Material (Bio-based, Microbial Synthesized, Synthetic, Partially Bio-based), By...